FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3107941102> ?p ?o ?g. }

• W3107941102 abstract "Abstract Background Acute bronchiolitis caused by respiratory syncytial virus (RSV) has been associated with greater risk of recurrent wheezing and asthma. However, it is unclear whether this association is causal. RSV-specific monoclonal antibodies have been shown to reduce RSV-related hospitalisations in high-risk infants, but the longer-term follow-up has given conflicting evidence for prevention of recurrent wheeze or asthma. Objective We performed a systematic review and meta-analysis to determine whether monoclonal antibody prophylaxis against RSV bronchiolitis reduces the risk of subsequent recurrent wheeze or asthma. If so, this may support the hypothesis of causality. Methods Studies were identified via an online database search using Embase, MEDLINE, PubMed, Web of Science and the Cochrane Library. Manufacturers of monoclonal antibodies were contacted directly for unpublished data. The intervention of interest was RSV monoclonal antibody prophylaxis, and the primary outcome measure was recurrent wheeze and/or asthma. Studies were screened according to inclusion/exclusion criteria. Included studies were evaluated for quality and assessed for bias independently by 3 reviewers using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) approach. Results were extracted into 2 × 2 outcome tables and a meta-analysis carried out producing forest plots based on relative risk. Heterogeneity was assessed using the I 2 statistic. Results The search identified 141 articles, which, after screening, resulted in eight studies (2 randomised controlled trials), thus including 11,195 infants in the meta-analysis. The overall result demonstrated a non-statistically significant reduction in relative risk of developing recurrent wheeze or asthma (RR 0.60; 95% CI 0.31 to 1.16). Study quality was generally low with evidence of publication bias and statistical heterogeneity. However, sub-group analysis excluding studies deemed to be ‘very low’ quality showed a relative risk of 0.42 (95% CI 0.22 to 0.80, p = 0.008). A further sub-group analysis for infants aged 32 to < 36 weeks showed a statistically significant relative risk of 0.35 (95% CI 0.14 to 0.86, p = 0.02). Discussion We did not identify an overall statistically significant benefit. However, our two sub-group analyses did find statistically significant benefits of monoclonal antibody therapy on the risk of recurrent wheeze and asthma. The main limitation of this study is the lack of high-quality randomised controlled trials, highlighting the need for more research in this field." @default.
• W3107941102 created "2020-12-07" @default.
• W3107941102 creator A5068423549 @default.
• W3107941102 creator A5072520427 @default.
• W3107941102 creator A5083690668 @default.
• W3107941102 creator A5087865591 @default.
• W3107941102 date "2020-11-25" @default.
• W3107941102 modified "2023-10-14" @default.
• W3107941102 title "Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review" @default.
• W3107941102 cites W1962254654 @default.
• W3107941102 cites W1973250128 @default.
• W3107941102 cites W1975386460 @default.
• W3107941102 cites W1991218424 @default.
• W3107941102 cites W1992715791 @default.
• W3107941102 cites W2018672014 @default.
• W3107941102 cites W2031081480 @default.
• W3107941102 cites W2035573793 @default.
• W3107941102 cites W2044007895 @default.
• W3107941102 cites W2044508050 @default.
• W3107941102 cites W2076902286 @default.
• W3107941102 cites W2077290707 @default.
• W3107941102 cites W2086373045 @default.
• W3107941102 cites W2091726854 @default.
• W3107941102 cites W2123440983 @default.
• W3107941102 cites W2129823429 @default.
• W3107941102 cites W2133100940 @default.
• W3107941102 cites W2142073032 @default.
• W3107941102 cites W2146987033 @default.
• W3107941102 cites W2156098321 @default.
• W3107941102 cites W2166937404 @default.
• W3107941102 cites W2169665123 @default.
• W3107941102 cites W2223258418 @default.
• W3107941102 cites W2312397711 @default.
• W3107941102 cites W2317777333 @default.
• W3107941102 cites W2337928173 @default.
• W3107941102 cites W2443858981 @default.
• W3107941102 cites W2490831979 @default.
• W3107941102 cites W2625910786 @default.
• W3107941102 cites W2746473595 @default.
• W3107941102 cites W2765468853 @default.
• W3107941102 cites W2766041748 @default.
• W3107941102 cites W2782749981 @default.
• W3107941102 cites W2788404815 @default.
• W3107941102 cites W2793844201 @default.
• W3107941102 cites W2808415597 @default.
• W3107941102 cites W2884327392 @default.
• W3107941102 cites W2979898445 @default.
• W3107941102 cites W2991792334 @default.
• W3107941102 cites W4255884628 @default.
• W3107941102 doi "https://doi.org/10.1186/s13643-020-01527-y" @default.
• W3107941102 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7690183" @default.
• W3107941102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33239107" @default.
• W3107941102 hasPublicationYear "2020" @default.
• W3107941102 type Work @default.
• W3107941102 sameAs 3107941102 @default.
• W3107941102 citedByCount "14" @default.
• W3107941102 countsByYear W31079411022021 @default.
• W3107941102 countsByYear W31079411022022 @default.
• W3107941102 countsByYear W31079411022023 @default.
• W3107941102 crossrefType "journal-article" @default.
• W3107941102 hasAuthorship W3107941102A5068423549 @default.
• W3107941102 hasAuthorship W3107941102A5072520427 @default.
• W3107941102 hasAuthorship W3107941102A5083690668 @default.
• W3107941102 hasAuthorship W3107941102A5087865591 @default.
• W3107941102 hasBestOaLocation W31079411021 @default.
• W3107941102 hasConcept C126322002 @default.
• W3107941102 hasConcept C168563851 @default.
• W3107941102 hasConcept C17744445 @default.
• W3107941102 hasConcept C177713679 @default.
• W3107941102 hasConcept C187212893 @default.
• W3107941102 hasConcept C189708586 @default.
• W3107941102 hasConcept C199539241 @default.
• W3107941102 hasConcept C2776042228 @default.
• W3107941102 hasConcept C2776478404 @default.
• W3107941102 hasConcept C2778338976 @default.
• W3107941102 hasConcept C2778821649 @default.
• W3107941102 hasConcept C2779473830 @default.
• W3107941102 hasConcept C44249647 @default.
• W3107941102 hasConcept C534529494 @default.
• W3107941102 hasConcept C71924100 @default.
• W3107941102 hasConcept C82789193 @default.
• W3107941102 hasConcept C95190672 @default.
• W3107941102 hasConceptScore W3107941102C126322002 @default.
• W3107941102 hasConceptScore W3107941102C168563851 @default.
• W3107941102 hasConceptScore W3107941102C17744445 @default.
• W3107941102 hasConceptScore W3107941102C177713679 @default.
• W3107941102 hasConceptScore W3107941102C187212893 @default.
• W3107941102 hasConceptScore W3107941102C189708586 @default.
• W3107941102 hasConceptScore W3107941102C199539241 @default.
• W3107941102 hasConceptScore W3107941102C2776042228 @default.
• W3107941102 hasConceptScore W3107941102C2776478404 @default.
• W3107941102 hasConceptScore W3107941102C2778338976 @default.
• W3107941102 hasConceptScore W3107941102C2778821649 @default.
• W3107941102 hasConceptScore W3107941102C2779473830 @default.
• W3107941102 hasConceptScore W3107941102C44249647 @default.
• W3107941102 hasConceptScore W3107941102C534529494 @default.
• W3107941102 hasConceptScore W3107941102C71924100 @default.
• W3107941102 hasConceptScore W3107941102C82789193 @default.
• W3107941102 hasConceptScore W3107941102C95190672 @default.
• W3107941102 hasIssue "1" @default.

• next